Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
83.81
-2.93 (-3.38%)
At close: Apr 28, 2026, 4:00 PM EDT
83.55
-0.26 (-0.31%)
After-hours: Apr 28, 2026, 7:58 PM EDT
Nektar Therapeutics Employees
Nektar Therapeutics had 63 employees as of December 31, 2025. The number of employees increased by 2 or 3.28% compared to the previous year.
Employees
63
Change (1Y)
2
Growth (1Y)
3.28%
Revenue / Employee
$876,698
Profits / Employee
-$2,604,381
Market Cap
2.83B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Beam Therapeutics | 511 |
| Tarsus Pharmaceuticals | 370 |
| Arcutis Biotherapeutics | 354 |
| Dyne Therapeutics | 258 |
| Vera Therapeutics | 249 |
| Alumis | 224 |
| Celldex Therapeutics | 198 |
| Soleno Therapeutics | 182 |
NKTR News
- 6 hours ago - Nektar to Announce Financial Results for the First Quarter on Thursday, May 7, 2026, After Close of U.S.-Based Financial Markets - PRNewsWire
- 8 hours ago - Pomerantz Law Firm Announces the Filing of a Class Action Against Nektar Therapeutics and Certain Officers – NKTR - GlobeNewsWire
- 15 hours ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 5, 2026 in Nektar Therapeutics Lawsuit - NKTR - PRNewsWire
- 5 days ago - Nektar Therapeutics Announces Closing of $373.8 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares - PRNewsWire
- 7 days ago - Nektar Therapeutics Announces Pricing of Upsized $325 Million Public Offering - PRNewsWire
- 8 days ago - Nektar Therapeutics Announces Proposed Public Offering - PRNewsWire
- 8 days ago - This Biotech Stock Soars on Hair Loss Trial Results. It's Not a Cure for Baldness. - Barrons
- 8 days ago - Why Are Nektar Shares Up Monday? - Benzinga